Switching from Wellbutrin 200mg SR BID to Adderall
You should taper Wellbutrin gradually over 1-2 weeks while simultaneously initiating Adderall at a low starting dose, as bupropion does not require an extended washout period and this cross-taper approach minimizes the risk of symptom exacerbation during the transition. 1, 2
Rationale for Cross-Tapering
- Bupropion can be safely discontinued while starting stimulant therapy because it works through noradrenergic/dopaminergic pathways and does not pose significant drug interaction risks with amphetamines. 1
- Cross-tapering is generally the most acceptable method of switching psychiatric medications, as it avoids prolonged periods without treatment and reduces the risk of symptom exacerbation. 2, 3
- Conservative switching strategies that involve complete washout periods can take a long time and include periods of no treatment with the risk of potentially life-threatening exacerbations of illness. 2
Specific Tapering Protocol for Wellbutrin
Week 1:
- Reduce Wellbutrin SR from 200mg BID (400mg total daily) to 150mg BID (300mg total daily). 1
- Administer doses in the morning and before 3 PM to minimize insomnia risk during the taper. 1
Week 2:
- Further reduce to 150mg once daily in the morning. 1
- Gradual dose reduction over days to weeks reduces the risk and severity of withdrawal complications. 2
Week 3:
- Discontinue Wellbutrin completely after the 1-2 week taper. 2
Initiating Adderall
- Start Adderall at a low dose (typically 5-10mg once or twice daily) while tapering Wellbutrin, rather than waiting for complete discontinuation. 2
- Stimulants have a rapid effect, allowing for quick assessment of tolerability and efficacy. 4
- Monitor closely for increased agitation or activation, as both medications have activating properties. 1
Critical Monitoring Parameters
During the transition (weeks 1-3):
- Watch for withdrawal symptoms from bupropion, including mood changes, irritability, or return of depressive symptoms. 2
- Monitor blood pressure, as both medications can increase blood pressure, though this is more pronounced with stimulants. 1
- Assess for excessive activation, anxiety, or insomnia from the combination during cross-taper. 1
After completing the switch:
- Recognize that approximately 41% of medication-naive adults with ADHD require switching from their initially prescribed stimulant family due to poor tolerability within 90 days. 5
- If Adderall is not well-tolerated, consider switching to methylphenidate-based products rather than returning to bupropion. 5
Important Caveats
- Bupropion is not as efficacious as stimulants for ADHD treatment, so patients should understand this is a switch to more effective therapy if ADHD is the primary indication. 4
- If depression is a co-occurring condition requiring ongoing treatment, consider adding an SSRI rather than relying solely on Adderall, as stimulants are not primary treatments for depression. 4
- Avoid abrupt discontinuation of Wellbutrin after prolonged use, as this can cause withdrawal syndromes and relapse of depression. 2
- Ensure the patient does not have seizure disorders or uncontrolled hypertension before initiating either medication, though this is particularly critical for Wellbutrin. 1
Timeline Expectations
- The entire switching process should take 2-3 weeks from initiation of taper to full transition to Adderall monotherapy. 2
- Stimulant effects are typically apparent within days, allowing rapid assessment of whether the switch is beneficial. 4
- Allow adequate time (at least 6-8 weeks at therapeutic Adderall doses) to fully assess treatment response before making further medication changes. 1